Vimarsana
Biggest News Aggregation in the World

Page 6 - Evidence Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evidence Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evidence Development Today - Breaking & Trending Today

TAKE TWO: CMS's Second Attempt to Streamline Breakthrough Device Coverage Limited to 5 Devices Per Year | Epstein Becker & Green - Vimarsana News

TAKE TWO: CMS's Second Attempt to Streamline Breakthrough Device Coverage Limited to 5 Devices Per Year | Epstein Becker & Green

On June 22, 2023, the Centers for Medicare & Medicaid Services (CMS) announced its proposed “Transitional Coverage for Technologies” (TCET) pathway—the Biden administration’s highly...

CMS Must Work Harder to Get New Drugs and Devices Covered Quickly, House Members Say - Vimarsana News

CMS Must Work Harder to Get New Drugs and Devices Covered Quickly, House Members Say

Committee chair expresses concern about agency's lack of a 'predictable coverage pathway'

A Pathway for Medicare Coverage for Breakthrough Devices: Take Two | King & Spalding - Vimarsana News

A Pathway for Medicare Coverage for Breakthrough Devices: Take Two | King & Spalding

On June 27, 2023, the Centers for Medicare & Medicaid Services (“CMS” or the “Agency”) issued a “Notice with Comment Period” (“Notice”) describing a new process for providing expedited...

CMS Proposes Transitional Coverage For Emergency Technologies - Healthcare - Vimarsana News

CMS Proposes Transitional Coverage For Emergency Technologies - Healthcare

On June 22, 2023, the Centers for Medicare & Medicaid Services (CMS) released a long-awaited procedural notice with comment period (CMS-3421-NC) that outlines a proposed Transitional Coverage...

Source: mondaq.com
MedPAC Recommends Cutting Admin Fees Paid to Docs Under Part B Program - Vimarsana News

MedPAC Recommends Cutting Admin Fees Paid to Docs Under Part B Program

The goal is to make providers more sensitive to drug costs, says MedPAC's director